The increased focus on the safety of drugs and biologics and volume of safety data creates a need for objective quantitative approaches to supplement the medical review of individual case safety reports
Emeryville, CA (PRWEB) December 13, 2011
BioSoteria, Inc., Drug Safety and Risk Management Specialists, announced today that its President and Chief Executive Officer, Sally Van Doren, PharmD, will co-instruct the tutorial, "Signal Detection, Case Assessment and Data Mining in Pharmacovigilance: Current State of the Art” with Sheila Weiss Smith, PhD, MS, FISPE, Professor of pharmaceutical health services research at University of Maryland School of Pharmacy. The tutorial is part of the Drug Information Association’s (DIA) Pharmacovigilance and Risk Management conference to be held at the Sheraton National Hotel in Arlington. The tutorial will be offered on Sunday, January 22, 2012, 8:30 AM - 12:00 PM. The tutorial will focus on application of data mining techniques to safety surveillance and signal detection and the critical role of clinical case and case series assessment. “The increased focus on the safety of drugs and biologics and volume of safety data creates a need for objective quantitative approaches to supplement the medical review of individual case safety reports”, says Dr. Van Doren. “This course is designed to be a practical, hands-on tutorial so participants can easily apply the principles of signal detection and data mining in their own practices”.
BioSoteria will also exhibit during the conference, Monday, January 23 - Thursday, January 25, 2012, 8:00 AM– 5:00 PM. The Sheraton National Hotel located at 900 South Orme Street, Arlington, VA.
DIA is a neutral, nonprofit, global, professional association of nearly 18,000 members who work in every facet of the discovery, development, and life cycle management of pharmaceuticals, medical devices, and related products.
Founded in 2007 with a strong vision of a progressive drug safety and pharmacovigilance consulting services and education, BioSoteria serves the outsourcing needs of the pharmaceutical industry. From strategic risk management consulting services and full-service drug safety operational capabilities to world-class award winning pharmacovigilance training and education programs, BioSoteria provides unmatched experience, expertise, and leadership to support your company’s efforts to maximize your product’s benefit-risk profile. For more information and to learn more about BioSoteria’s drug safety services and training programs go to http://www.biosoteria.com.